Lichen China Key Executives
This section highlights Lichen China's key executives, including their titles and compensation details.
Find Contacts at Lichen China
(Showing 0 of )
Lichen China Earnings
This section highlights Lichen China's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|
Financial Statements
Access annual & quarterly financial statements for Lichen China, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|
Revenue | $39.76M | $33.80M | $34.30M | $30.67M | $31.60M |
Cost of Revenue | $15.44M | $13.61M | $13.82M | $11.83M | $12.26M |
Gross Profit | $24.32M | $20.19M | $20.48M | $18.84M | $19.34M |
Gross Profit Ratio | 61.17% | 59.73% | 59.70% | 61.42% | 61.21% |
Research and Development Expenses | $- | $1.06M | $1.08M | $930.00K | $- |
General and Administrative Expenses | $8.94M | $7.43M | $7.17M | $8.46M | $7.87M |
Selling and Marketing Expenses | $3.12M | $2.11M | $2.01M | $1.59M | $1.75M |
Selling General and Administrative Expenses | $12.06M | $9.54M | $9.18M | $10.05M | $9.62M |
Other Expenses | $- | $34.00K | $188.00K | $106.00K | $- |
Operating Expenses | $12.06M | $9.54M | $9.18M | $10.05M | $9.62M |
Cost and Expenses | $27.50M | $23.16M | $23.00M | $21.88M | $21.88M |
Interest Income | $38.00K | $60.00K | $28.00K | $103.00K | $49.00K |
Interest Expense | $- | $- | $- | $- | $49.00K |
Depreciation and Amortization | $2.92M | $2.66M | $2.45M | $2.25M | $2.19M |
EBITDA | $15.18M | $11.35M | $12.05M | $9.59M | $11.97M |
EBITDA Ratio | 38.19% | 33.57% | 35.14% | 31.28% | 37.88% |
Operating Income | $12.26M | $10.65M | $11.30M | $8.79M | $9.73M |
Operating Income Ratio | 30.83% | 31.50% | 32.94% | 28.65% | 30.78% |
Total Other Income Expenses Net | $-671.00K | $94.00K | $216.00K | $209.00K | $5.00K |
Income Before Tax | $11.59M | $10.74M | $11.51M | $9.00M | $9.73M |
Income Before Tax Ratio | 29.15% | 31.78% | 33.57% | 29.33% | 30.80% |
Income Tax Expense | $3.25M | $2.92M | $3.05M | $2.59M | $2.66M |
Net Income | $8.34M | $7.82M | $8.46M | $6.41M | $7.07M |
Net Income Ratio | 20.97% | 23.13% | 24.67% | 20.89% | 22.37% |
EPS | $0.31 | $0.35 | $0.29 | $0.22 | $0.25 |
EPS Diluted | $0.31 | $0.35 | $0.29 | $0.22 | $0.25 |
Weighted Average Shares Outstanding | 26.51M | 22.50M | 28.75M | 28.75M | 28.75M |
Weighted Average Shares Outstanding Diluted | 26.51M | 22.50M | 28.75M | 28.75M | 28.75M |
SEC Filing | Source | Source | Source | Source | Source |
Breakdown | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $9.05M | $9.05M | $11.92M | $11.92M | $7.96M | $7.96M | $8.83M | $8.83M | $8.07M | $8.07M | $8.65M | $8.65M | $8.49M | $8.49M | $9.00M | $9.00M | $6.33M | $6.33M |
Cost of Revenue | $3.57M | $3.57M | $4.67M | $4.67M | $3.05M | $3.05M | $3.93M | $3.93M | $2.87M | $2.87M | $4.07M | $4.07M | $2.84M | $2.84M | $3.44M | $3.44M | $2.48M | $2.48M |
Gross Profit | $5.48M | $5.48M | $7.25M | $7.25M | $4.91M | $4.91M | $4.89M | $4.89M | $5.20M | $5.20M | $4.58M | $4.58M | $5.66M | $5.66M | $5.56M | $5.56M | $3.86M | $3.86M |
Gross Profit Ratio | 60.59% | 60.59% | 60.81% | 60.81% | 61.71% | 61.71% | 55.44% | 55.44% | 64.42% | 64.42% | 52.94% | 52.94% | 66.60% | 66.60% | 61.80% | 61.80% | 60.88% | 60.88% |
Research and Development Expenses | $- | $- | $595.00K | $595.00K | $- | $- | $530.00K | $530.00K | $- | $- | $290.00K | $290.00K | $250.00K | $250.00K | $215.00K | $215.00K | $250.00K | $250.00K |
General and Administrative Expenses | $2.74M | $2.74M | $2.18M | $2.18M | $2.29M | $2.29M | $1.85M | $1.85M | $1.86M | $1.86M | $1.74M | $1.74M | $1.84M | $1.84M | $2.29M | $2.29M | $1.94M | $1.94M |
Selling and Marketing Expenses | $1.89M | $1.89M | $365.50K | $365.50K | $1.20M | $1.20M | $600.50K | $600.50K | $455.00K | $455.00K | $526.50K | $526.50K | $478.00K | $478.00K | $534.00K | $534.00K | $261.00K | $261.00K |
Selling General and Administrative Expenses | $4.63M | $4.63M | $2.54M | $2.54M | $3.49M | $3.49M | $2.45M | $2.45M | $2.32M | $2.32M | $2.27M | $2.27M | $2.32M | $2.32M | $2.82M | $2.82M | $2.20M | $2.20M |
Other Expenses | $- | $- | $-595.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Operating Expenses | $4.63M | $4.63M | $2.54M | $2.54M | $3.85M | $3.85M | $2.51M | $2.51M | $2.24M | $2.24M | $2.18M | $2.18M | $2.31M | $2.31M | $2.80M | $2.80M | $2.17M | $2.17M |
Cost and Expenses | $8.20M | $8.20M | $7.21M | $7.21M | $6.90M | $6.90M | $6.45M | $6.45M | $5.12M | $5.12M | $6.25M | $6.25M | $5.15M | $5.15M | $6.24M | $6.24M | $4.65M | $4.65M |
Interest Income | $- | $- | $7.50K | $7.50K | $11.50K | $11.50K | $16.00K | $16.00K | $14.00K | $14.00K | $1.50K | $1.50K | $12.50K | $12.50K | $61.50K | $61.50K | $10.00K | $10.00K |
Interest Expense | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Depreciation and Amortization | $199.00K | $199.00K | $119.00K | $119.00K | $257.50K | $257.50K | $256.50K | $256.50K | $94.00K | $94.00K | $148.50K | $148.50K | $228.00K | $228.00K | $229.00K | $229.00K | $174.00K | $174.00K |
EBITDA | $1.05M | $1.05M | $4.82M | $4.82M | $1.68M | $1.68M | $2.70M | $2.70M | $2.98M | $2.98M | $2.46M | $2.46M | $3.56M | $3.56M | $2.97M | $2.97M | $1.83M | $1.83M |
EBITDA Ratio | 11.60% | 11.60% | 40.47% | 40.47% | 21.14% | 21.14% | 30.54% | 30.54% | 36.89% | 36.89% | 28.46% | 28.46% | 41.95% | 41.95% | 32.98% | 32.98% | 28.87% | 28.87% |
Operating Income | $851.00K | $851.00K | $4.70M | $4.70M | $1.43M | $1.43M | $2.44M | $2.44M | $2.88M | $2.88M | $2.31M | $2.31M | $3.33M | $3.33M | $2.74M | $2.74M | $1.65M | $1.65M |
Operating Income Ratio | 9.41% | 9.41% | 39.47% | 39.47% | 17.91% | 17.91% | 27.64% | 27.64% | 35.72% | 35.72% | 26.74% | 26.74% | 39.27% | 39.27% | 30.43% | 30.43% | 26.12% | 26.12% |
Total Other Income Expenses Net | $32.50K | $32.50K | $14.00K | $14.00K | $-349.50K | $-349.50K | $-41.00K | $-41.00K | $88.00K | $88.00K | $88.50K | $88.50K | $19.50K | $19.50K | $83.00K | $83.00K | $21.50K | $21.50K |
Income Before Tax | $883.50K | $883.50K | $4.72M | $4.72M | $1.08M | $1.08M | $2.40M | $2.40M | $2.97M | $2.97M | $2.40M | $2.40M | $3.35M | $3.35M | $2.82M | $2.82M | $1.68M | $1.68M |
Income Before Tax Ratio | 9.76% | 9.76% | 39.59% | 39.59% | 13.52% | 13.52% | 27.17% | 27.17% | 36.81% | 36.81% | 27.76% | 27.76% | 39.49% | 39.49% | 31.36% | 31.36% | 26.46% | 26.46% |
Income Tax Expense | $500.00K | $500.00K | $1.23M | $1.23M | $398.00K | $398.00K | $655.00K | $655.00K | $807.00K | $807.00K | $608.50K | $608.50K | $917.50K | $917.50K | $790.50K | $790.50K | $504.00K | $504.00K |
Net Income | $383.50K | $383.50K | $3.49M | $3.49M | $678.50K | $678.50K | $1.74M | $1.74M | $2.17M | $2.17M | $1.79M | $1.79M | $2.44M | $2.44M | $2.03M | $2.03M | $1.17M | $1.17M |
Net Income Ratio | 4.24% | 4.24% | 29.29% | 29.29% | 8.52% | 8.52% | 19.75% | 19.75% | 26.82% | 26.82% | 20.73% | 20.73% | 28.69% | 28.69% | 22.57% | 22.57% | 18.50% | 18.50% |
EPS | $0.03 | $0.03 | $0.13 | $0.13 | $0.03 | $0.03 | $0.08 | $0.08 | $0.10 | $0.10 | $0.08 | $0.08 | $0.11 | $0.11 | $0.09 | $0.09 | $0.05 | $0.05 |
EPS Diluted | $0.03 | $0.03 | $0.13 | $0.13 | $0.03 | $0.03 | $0.08 | $0.08 | $0.10 | $0.10 | $0.08 | $0.08 | $0.11 | $0.11 | $0.09 | $0.09 | $0.05 | $0.05 |
Weighted Average Shares Outstanding | 14.87M | 14.87M | 26.51M | 26.51M | 25.64M | 25.64M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M |
Weighted Average Shares Outstanding Diluted | 14.87M | 14.87M | 26.51M | 26.51M | 25.64M | 25.64M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M | 22.50M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $25.86M | $22.60M | $16.84M | $8.66M | $5.39M |
Short Term Investments | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $25.86M | $22.60M | $16.84M | $8.66M | $5.39M |
Net Receivables | $4.46M | $3.54M | $4.36M | $2.83M | $1.88M |
Inventory | $87.00K | $127.00K | $150.00K | $23.00K | $33.00K |
Other Current Assets | $9.72M | $996.00K | $2.53M | $130.00K | $118.00K |
Total Current Assets | $40.13M | $27.27M | $23.89M | $11.65M | $7.42M |
Property Plant Equipment Net | $14.76M | $13.50M | $14.94M | $15.77M | $15.46M |
Goodwill | $- | $- | $- | $- | $- |
Intangible Assets | $6.03M | $4.52M | $3.87M | $5.59M | $5.51M |
Goodwill and Intangible Assets | $6.03M | $4.52M | $3.87M | $5.59M | $5.51M |
Long Term Investments | $- | $- | $- | $- | $- |
Tax Assets | $- | $- | $- | $- | $- |
Other Non-Current Assets | $4.63M | $1.24M | $250.00K | $337.00K | $401.00K |
Total Non-Current Assets | $25.41M | $19.26M | $19.05M | $21.70M | $21.37M |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $65.55M | $46.52M | $42.94M | $33.35M | $28.79M |
Account Payables | $61.00K | $161.00K | $123.00K | $95.00K | $85.00K |
Short Term Debt | $95.00K | $88.00K | $345.00K | $337.00K | $315.00K |
Tax Payables | $1.59M | $1.06M | $1.20M | $1.05M | $77.00K |
Deferred Revenue | $1.03M | $1.15M | $1.27M | $1.10M | $1.18M |
Other Current Liabilities | $1.31M | $2.78M | $3.17M | $3.12M | $3.41M |
Total Current Liabilities | $4.09M | $5.23M | $6.11M | $5.71M | $5.07M |
Long Term Debt | $34.00K | $184.00K | $- | $- | $- |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $- | $- | $- | $- | $- |
Total Non-Current Liabilities | $34.00K | $184.00K | $- | $- | $- |
Other Liabilities | $- | $- | $- | $- | $- |
Total Liabilities | $4.12M | $5.42M | $6.11M | $5.71M | $5.07M |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K |
Retained Earnings | $48.22M | $40.83M | $33.01M | $24.55M | $22.49M |
Accumulated Other Comprehensive Income Loss | $-1.70M | $-1.21M | $2.33M | $1.60M | $-256.00K |
Other Total Stockholders Equity | $14.89M | $1.49M | $1.49M | $1.49M | $1.49M |
Total Stockholders Equity | $61.42M | $41.11M | $36.83M | $27.64M | $23.73M |
Total Equity | $61.42M | $41.11M | $36.83M | $27.64M | $23.73M |
Total Liabilities and Stockholders Equity | $65.55M | $46.52M | $42.94M | $33.35M | $28.79M |
Minority Interest | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $65.55M | $46.52M | $42.94M | $33.35M | $28.79M |
Total Investments | $- | $- | $- | $- | $- |
Total Debt | $129.00K | $272.00K | $345.00K | $337.00K | $315.00K |
Net Debt | $-25.73M | $-22.33M | $-16.50M | $-8.33M | $-5.08M |
Balance Sheet Charts
Breakdown | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $34.19M | $34.19M | $25.86M | $25.86M | $18.81M | $18.81M | $22.60M | $22.60M | $20.16M | $20.16M | $16.84M | $16.84M | $12.30M | $12.30M | $8.66M | $8.66M | $-5.39M |
Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $10.78M |
Cash and Short Term Investments | $34.19M | $34.19M | $25.86M | $25.86M | $18.81M | $18.81M | $22.60M | $22.60M | $20.16M | $20.16M | $16.84M | $16.84M | $12.30M | $12.30M | $8.66M | $8.66M | $5.39M |
Net Receivables | $2.95M | $2.95M | $4.46M | $4.46M | $2.72M | $2.72M | $3.54M | $3.54M | $3.92M | $3.92M | $3.94M | $3.94M | $3.83M | $3.83M | $2.42M | $2.42M | $- |
Inventory | $54.00K | $54.00K | $87.00K | $87.00K | $128.00K | $128.00K | $127.00K | $127.00K | $193.00K | $193.00K | $150.00K | $150.00K | $201.00K | $201.00K | $23.00K | $23.00K | $- |
Other Current Assets | $11.98M | $11.98M | $9.72M | $9.72M | $8.13M | $8.13M | $996.00K | $996.00K | $355.00K | $355.00K | $2.53M | $2.95M | $1.99M | $1.99M | $546.00K | $546.00K | $- |
Total Current Assets | $49.17M | $49.17M | $40.13M | $40.13M | $29.79M | $29.79M | $27.27M | $27.27M | $24.62M | $24.62M | $23.89M | $23.89M | $18.32M | $18.32M | $11.65M | $11.65M | $5.39M |
Property Plant Equipment Net | $14.23M | $14.23M | $14.76M | $14.76M | $14.49M | $14.49M | $13.50M | $13.50M | $13.91M | $13.91M | $14.94M | $14.94M | $15.52M | $15.52M | $15.77M | $15.77M | $- |
Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Intangible Assets | $4.62M | $4.62M | $6.03M | $6.03M | $3.88M | $3.88M | $4.52M | $4.52M | $5.81M | $5.81M | $3.87M | $3.87M | $4.74M | $4.74M | $5.59M | $5.59M | $- |
Goodwill and Intangible Assets | $4.62M | $4.62M | $6.03M | $6.03M | $3.88M | $3.88M | $4.52M | $4.52M | $5.81M | $5.81M | $3.87M | $3.87M | $4.74M | $4.74M | $5.59M | $5.59M | $- |
Long Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Assets | $4.56M | $4.56M | $4.63M | $4.63M | $8.04M | $8.04M | $1.24M | $1.24M | $194.00K | $194.00K | $250.00K | $250.00K | $294.00K | $294.00K | $337.00K | $337.00K | $-5.39M |
Total Non-Current Assets | $23.42M | $23.42M | $25.41M | $25.41M | $26.40M | $26.40M | $19.26M | $19.26M | $19.91M | $19.91M | $19.05M | $19.05M | $20.55M | $20.55M | $21.70M | $21.70M | $-5.39M |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $72.59M | $72.59M | $65.55M | $65.55M | $56.19M | $56.19M | $46.52M | $46.52M | $44.54M | $44.54M | $42.94M | $42.94M | $38.87M | $38.87M | $33.35M | $33.35M | $- |
Account Payables | $79.00K | $79.00K | $61.00K | $61.00K | $68.00K | $68.00K | $161.00K | $161.00K | $179.00K | $179.00K | $123.00K | $123.00K | $156.00K | $156.00K | $95.00K | $95.00K | $- |
Short Term Debt | $74.00K | $74.00K | $95.00K | $- | $66.00K | $- | $88.00K | $- | $- | $- | $345.00K | $345.00K | $341.00K | $341.00K | $337.00K | $337.00K | $- |
Tax Payables | $- | $- | $1.59M | $- | $459.00K | $- | $1.06M | $- | $1.23M | $- | $1.20M | $- | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $- | $1.03M | $- | $920.00K | $- | $1.15M | $- | $1.05M | $- | $1.27M | $- | $- | $- | $- | $- | $- |
Other Current Liabilities | $2.65M | $2.65M | $1.31M | $4.03M | $1.32M | $2.76M | $2.78M | $5.07M | $2.98M | $5.25M | $3.17M | $5.64M | $5.35M | $5.35M | $5.27M | $5.27M | $- |
Total Current Liabilities | $2.80M | $2.80M | $4.09M | $4.09M | $2.83M | $2.83M | $5.23M | $5.23M | $5.43M | $5.43M | $6.11M | $6.11M | $5.84M | $5.84M | $5.71M | $5.71M | $- |
Long Term Debt | $8.00K | $8.00K | $34.00K | $34.00K | $86.00K | $86.00K | $184.00K | $184.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Non-Current Liabilities | $8.00K | $8.00K | $34.00K | $34.00K | $86.00K | $86.00K | $184.00K | $184.00K | $1.23M | $- | $1.74M | $- | $- | $- | $- | $- | $- |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $-1.23M | $- | $-1.74M | $- | $- | $- | $- | $- | $- |
Total Liabilities | $2.81M | $2.81M | $4.12M | $4.12M | $2.92M | $2.92M | $5.42M | $5.42M | $5.43M | $5.43M | $6.11M | $6.11M | $5.84M | $5.84M | $5.71M | $5.71M | $- |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $2.00K | $2.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $1.00K | $- |
Retained Earnings | $50.73M | $50.73M | $49.96M | $49.96M | $42.19M | $42.98M | $40.83M | $41.62M | $37.34M | $38.13M | $33.01M | $33.80M | $30.21M | $30.21M | $25.34M | $25.34M | $- |
Accumulated Other Comprehensive Income Loss | $-4.11M | $-4.11M | $-1.70M | $-3.43M | $-3.81M | $-4.60M | $-1.21M | $-2.00M | $271.00K | $-518.00K | $2.33M | $1.54M | $1.32M | $1.32M | $814.00K | $814.00K | $23.73M |
Other Total Stockholders Equity | $23.17M | $23.17M | $13.16M | $14.89M | $14.89M | $14.89M | $2.28M | $1.49M | $2.28M | $1.49M | $2.28M | $1.49M | $1.49M | $1.49M | $1.49M | $1.49M | $- |
Total Stockholders Equity | $69.78M | $69.78M | $61.42M | $61.42M | $53.28M | $53.28M | $41.11M | $41.11M | $39.10M | $39.10M | $36.83M | $36.83M | $33.03M | $33.03M | $27.64M | $27.64M | $23.73M |
Total Equity | $69.78M | $69.78M | $61.42M | $61.42M | $53.28M | $53.28M | $41.11M | $41.11M | $39.10M | $39.10M | $36.83M | $36.83M | $33.03M | $33.03M | $27.64M | $27.64M | $23.73M |
Total Liabilities and Stockholders Equity | $72.59M | $72.59M | $65.55M | $65.55M | $56.19M | $56.19M | $46.52M | $46.52M | $44.54M | $44.54M | $42.94M | $42.94M | $38.87M | $38.87M | $33.35M | $33.35M | $23.73M |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $72.59M | $72.59M | $65.55M | $65.55M | $56.19M | $56.19M | $46.52M | $46.52M | $44.54M | $44.54M | $42.94M | $42.94M | $38.87M | $38.87M | $33.35M | $33.35M | $23.73M |
Total Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $10.78M |
Total Debt | $82.00K | $82.00K | $129.00K | $34.00K | $152.00K | $86.00K | $272.00K | $184.00K | $- | $- | $345.00K | $345.00K | $341.00K | $341.00K | $337.00K | $337.00K | $- |
Net Debt | $-34.10M | $-34.10M | $-25.73M | $-25.82M | $-18.66M | $-18.73M | $-22.33M | $-22.41M | $-20.16M | $-20.16M | $-16.50M | $-16.50M | $-11.96M | $-11.96M | $-8.33M | $-8.33M | $5.39M |
Annual Cash Flow
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|
Net Income | $8.34M | $7.82M | $8.46M | $6.41M | $7.07M |
Depreciation and Amortization | $2.92M | $2.68M | $2.45M | $2.16M | $2.19M |
Deferred Income Tax | $- | $- | $- | $- | $- |
Stock Based Compensation | $- | $- | $- | $- | $- |
Change in Working Capital | $-10.78M | $217.00K | $-3.67M | $-304.00K | $4.31M |
Accounts Receivables | $-982.00K | $66.00K | $-1.45M | $-465.00K | $-2.36M |
Inventory | $38.00K | $11.00K | $-126.00K | $11.00K | $3.00K |
Accounts Payables | $-98.00K | $51.00K | $25.00K | $4.00K | $64.00K |
Other Working Capital | $-9.73M | $89.00K | $-2.12M | $146.00K | $6.61M |
Other Non Cash Items | $72.00K | $50.00K | $63.00K | $87.00K | $6.67M |
Net Cash Provided by Operating Activities | $557.00K | $10.77M | $7.30M | $8.35M | $13.57M |
Investments in Property Plant and Equipment | $-5.27M | $-2.84M | $-28.00K | $-1.16M | $-10.83M |
Acquisitions Net | $- | $- | $589.00K | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- |
Other Investing Activities | $-4.60M | $-892.00K | $589.00K | $-1.16M | $-6.09M |
Net Cash Used for Investing Activities | $-9.87M | $-2.84M | $561.00K | $-1.16M | $-10.83M |
Debt Repayment | $- | $-327.00K | $- | $- | $- |
Common Stock Issued | $14.10M | $- | $- | $- | $- |
Common Stock Repurchased | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $-4.35M | $-7.25M |
Other Financing Activities | $14.10M | $- | $- | $- | $-1.74M |
Net Cash Used Provided by Financing Activities | $14.10M | $-327.00K | $- | $-4.35M | $-8.99M |
Effect of Forex Changes on Cash | $-1.53M | $-1.84M | $315.00K | $433.00K | $-99.00K |
Net Change in Cash | $3.26M | $5.75M | $8.18M | $3.27M | $376.18K |
Cash at End of Period | $25.86M | $22.60M | $16.84M | $8.66M | $5.39M |
Cash at Beginning of Period | $22.60M | $16.84M | $8.66M | $5.39M | $5.01M |
Operating Cash Flow | $557.00K | $10.77M | $7.30M | $8.35M | $13.57M |
Capital Expenditure | $-7.80M | $-2.84M | $-28.00K | $-1.16M | $-10.83M |
Free Cash Flow | $-4.71M | $7.92M | $7.28M | $7.19M | $2.74M |
Cash Flow Charts
Breakdown | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $383.50K | $383.50K | $3.49M | $3.49M | $678.50K | $678.50K | $1.74M | $1.74M | $2.17M | $2.17M | $1.79M | $1.79M | $2.44M | $2.44M | $2.03M | $2.03M | $1.17M | $1.17M |
Depreciation and Amortization | $878.00K | $878.00K | $141.50K | $141.50K | $281.00K | $281.00K | $292.50K | $292.50K | $94.00K | $94.00K | $148.50K | $148.50K | $228.00K | $228.00K | $229.00K | $229.00K | $174.00K | $174.00K |
Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Stock Based Compensation | $504.50K | $504.50K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Change in Working Capital | $764.00K | $764.00K | $-4.60M | $-4.60M | $-972.00K | $-972.00K | $62.00K | $62.00K | $53.50K | $53.50K | $-537.00K | $-537.00K | $-1.45M | $-1.45M | $126.00K | $126.00K | $-381.00K | $-381.00K |
Accounts Receivables | $743.50K | $743.50K | $-856.50K | $-856.50K | $365.50K | $365.50K | $124.00K | $124.00K | $-91.00K | $-91.00K | $-33.00K | $-33.00K | $-692.50K | $-692.50K | $-202.00K | $-202.00K | $-30.50K | $-30.50K |
Inventory | $16.00K | $16.00K | $22.00K | $22.00K | $-3.00K | $-3.00K | $32.00K | $32.00K | $-26.50K | $-26.50K | $26.00K | $26.00K | $-89.00K | $-89.00K | $3.50K | $3.50K | $2.00K | $2.00K |
Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Working Capital | $4.50K | $4.50K | $-3.76M | $-3.76M | $-1.33M | $-1.33M | $-94.00K | $-94.00K | $171.00K | $171.00K | $-530.00K | $-530.00K | $-664.00K | $-664.00K | $324.50K | $324.50K | $-352.50K | $-352.50K |
Other Non Cash Items | $-686.50K | $-686.50K | $1.30M | $1.30M | $-49.50K | $-49.50K | $693.50K | $693.50K | $278.50K | $278.50K | $466.50K | $466.50K | $560.50K | $560.50K | $319.00K | $319.00K | $504.50K | $504.50K |
Net Cash Provided by Operating Activities | $1.84M | $1.84M | $340.50K | $340.50K | $-62.00K | $-62.00K | $2.79M | $2.79M | $2.59M | $2.59M | $1.87M | $1.87M | $1.78M | $1.78M | $2.71M | $2.71M | $1.47M | $1.47M |
Investments in Property Plant and Equipment | $- | $- | $-1.15M | $-1.15M | $-2.75M | $-2.75M | $-959.50K | $-959.50K | $-15.50K | $-15.50K | $-14.00K | $-14.00K | $- | $- | $- | $- | $- | $- |
Acquisitions Net | $- | $- | $3.37M | $3.37M | $-3.37M | $-3.37M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Investing Activities | $-1.13M | $-1.13M | $772.50K | $772.50K | $-1.80M | $-1.80M | $16.50K | $16.50K | $-462.50K | $-462.50K | $294.50K | $294.50K | $- | $- | $-580.00K | $-580.00K | $- | $- |
Net Cash Used for Investing Activities | $-1.13M | $-1.13M | $2.99M | $2.99M | $-7.93M | $-7.93M | $-943.00K | $-943.00K | $-478.00K | $-478.00K | $280.50K | $280.50K | $- | $- | $-580.00K | $-580.00K | $- | $- |
Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-41.00K | $-41.00K | $-2.13M | $-2.13M |
Other Financing Activities | $3.63M | $3.63M | $- | $- | $7.05M | $7.05M | $6.00K | $6.00K | $-169.50K | $-169.50K | $- | $- | $- | $- | $- | $- | $- | $- |
Net Cash Used Provided by Financing Activities | $3.63M | $3.63M | $- | $- | $7.05M | $7.05M | $6.00K | $6.00K | $-169.50K | $-169.50K | $- | $- | $- | $- | $-41.00K | $-41.00K | $-2.13M | $-2.13M |
Effect of Forex Changes on Cash | $-185.00K | $-185.00K | $188.00K | $188.00K | $-954.50K | $-954.50K | $-632.50K | $-632.50K | $-289.00K | $-289.00K | $118.00K | $118.00K | $39.50K | $39.50K | $240.50K | $240.50K | $-24.00K | $-24.00K |
Net Change in Cash | $- | $- | $3.52M | $3.52M | $-1.89M | $-1.89M | $1.22M | $1.22M | $1.66M | $1.66M | $2.27M | $2.27M | $1.82M | $1.82M | $2.33M | $2.33M | $-687.50K | $-687.50K |
Cash at End of Period | $- | $- | $3.52M | $3.52M | $-1.89M | $-1.89M | $1.22M | $21.38M | $20.16M | $18.50M | $16.84M | $14.57M | $12.30M | $1.82M | $2.33M | $6.34M | $4.01M | $-687.50K |
Cash at Beginning of Period | $- | $- | $- | $- | $- | $- | $- | $20.16M | $18.50M | $16.84M | $14.57M | $12.30M | $10.48M | $- | $- | $4.01M | $4.70M | $- |
Operating Cash Flow | $1.84M | $1.84M | $340.50K | $340.50K | $-62.00K | $-62.00K | $2.79M | $2.79M | $2.59M | $2.59M | $1.87M | $1.87M | $1.78M | $1.78M | $2.71M | $2.71M | $1.47M | $1.47M |
Capital Expenditure | $- | $- | $-1.15M | $-1.15M | $-2.75M | $-2.75M | $-959.50K | $-959.50K | $-15.50K | $-15.50K | $-14.00K | $-14.00K | $- | $- | $- | $- | $- | $- |
Free Cash Flow | $1.84M | $1.84M | $-806.50K | $-806.50K | $-2.82M | $-2.82M | $1.83M | $1.83M | $2.58M | $2.58M | $1.86M | $1.86M | $1.78M | $1.78M | $2.71M | $2.71M | $1.47M | $1.47M |

Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sale of teaching and learning materials. It also provides Lichen Education Accounting Practice System V1.0, a financial and taxation training software, and academic affairs management system to partnered institutions under the partnership agreements, as well as offers software installation, training, and after sales technical and maintenance support services. The company was founded in 2004 and is based in Jinjiang, China. Lichen China Limited operates as a subsidiary of Silver Sky Investment Limited
$3.68
Stock Price
$2.60M
Market Cap
452
Employees
Jinjiang, None
Location
Revenue (FY 2023)
$39.76M
17.6% YoY
Net Income (FY 2023)
$8.34M
6.7% YoY
EPS (FY 2023)
$0.31
-11.4% YoY
Free Cash Flow (FY 2023)
$-4.71M
-159.4% YoY
Profitability
Gross Margin
61.2%
Net Margin
21.0%
ROE
13.6%
ROA
12.7%
Valuation
P/E Ratio
1258.92
P/S Ratio
264.01
EV/EBITDA
689.71
Market Cap
$2.60M
Revenue & Net Income
Profit Margins
Cash Flow Summary
Operating Cash Flow
$557.00K
-94.8% YoY
Free Cash Flow
$-4.71M
-159.4% YoY
Balance Sheet Summary
Total Assets
$65.55M
40.9% YoY
Total Debt
$129.00K
52.6% YoY
Shareholder Equity
$61.42M
26.8% YoY
Dividend Overview
No Dividend Data
Lichen China Limited doesn't currently pay dividends.
Lichen China Dividends
Explore Lichen China's dividend history, including dividend yield, payout ratio, and historical payments.
Lichen China News
Read the latest news about Lichen China, including recent articles, headlines, and updates.
Lichen China Limited Announces Effective Date of Reverse Stock Split and Name Change
XIAMEN, China , Feb. 27, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN ) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced the date of effectiveness and the ratio of a forthcoming reverse stock split (the "Reverse Split") of the Company's ordinary shares (the "Ordinary Shares"). On February 12, 2025, the Company announced, on a Current Report on Form 6-K, the voting results from the annual meeting of shareholders (the "Meeting") held on February 10, 2025.

Lichen China Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request
XIAMEN, China , Feb. 18, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN ) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying that the Company is not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule"), as the Company's securities had a closing bid price of $0.10 or less for eleven consecutive trading days from January 28, 2025 through February 11, 2025. The letter indicated that, as a result, the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delisting Determination").

Lichen China Limited Acquires Remaining Equity in Bondly Enterprises to Strengthen AI Development and Business Integration
XIAMEN, China , Feb. 10, 2025 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China") (NASDAQ: LICN), a leading financial and taxation service provider in China, today announced the completion of its acquisition of the remaining 40% equity interest in Bondly Enterprises Limited ("Bondly"), a prominent domestic consulting firm specializing in business process management and informationization. This acquisition follows Lichen China's initial purchase of 60% equity in Bondly in 2024, and marks a significant step in Lichen China's strategy to fully integrate Bondly's advanced technologies and AI capabilities into its operations.

Univest Securities, LLC Announces Closing of $3.4 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
New York, New York, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the of registered direct offering (the “Offering”) for its client Lichen China Limited (NASDAQ: LICN) (the “Company”), a dedicated financial and taxation service provider.

Lichen China Limited Announces $3.4 Million Registered Direct Offering
XIAMEN, China , Jan. 28, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 42,500,000 of the Company's Class A ordinary share, par value $0.00004 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $0.08 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share.

Lichen China Limited to Integrate DeepSeek Optimization into Its Financial and Taxation AI Model
XIAMEN, China , Jan. 28, 2025 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China") (NASDAQ: LICN), a leading provider of financial and taxation services in China, today announced its plans to integrate the DeepSeek optimization framework into its existing Lichen Financial and Taxation AI Model. This integration is expected to significantly enhance the AI's capabilities in handling complex financial and taxation tasks, offering more efficient and accurate solutions to its users.

Lichen China Limited Announces Receipt of Notification from Nasdaq
XIAMEN, China , Jan. 27, 2025 /PRNewswire/ --Lichen China Limited (Nasdaq: LICN ) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has received a written notification (the "Notification Letter") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on January 23, 2025. The Notification Letter advised the Company that for the last 30 consecutive business days, the minimum closing bid price per share for the Company's ordinary shares was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2).

Univest Securities, LLC Announces Closing of $3.1 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
New York, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) for its client Lichen China Limited (NASDAQ: LICN) (the “Company”), a dedicated financial and taxation service provider.

Lichen China Limited Announces $3.1 Million Registered Direct Offering
XIAMEN, China , Dec. 30, 2024 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 25,000,000 of the Company's Class A ordinary share, par value $0.00004 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $0.125 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share.

Univest Securities, LLC Announces Closing of $2.8 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
New York, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) for its client Lichen China Limited (NASDAQ: LICN) (the “Company”), a dedicated financial and taxation service provider.

Lichen China Limited Announces $2.8 Million Registered Direct Offering
XIAMEN, China , Dec. 26, 2024 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 20,000,000 of the Company's Class A ordinary share, par value $0.00004 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $0.14 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share.

Lichen China Limited Prepared To Launch Its AI Large-scale Model Developed With JD Technology
XIAMEN, China , Dec. 17, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ: LICN), a dedicated financial and taxation service provider in China, today announced that the AI large-scale model it has co-developed with JD Technology(JDT) is scheduled to commence its formal trial operation at the end of December. In October 2024, the Company entered into a cooperation framework agreement with JDT at the JD headquarters in Beijing.

Univest Securities, LLC Announces Closing of $2.7 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)
New York, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) for its client Lichen China Limited (NASDAQ: LICN) (the “Company”), a dedicated financial and taxation service provider.

Lichen China Limited Announces $2.70 Million Registered Direct Offering
XIAMEN, China , Dec. 12, 2024 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 15,000,000 of the Company's Class A ordinary share, par value $0.00004 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $0.18 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share.

Lichen China Limited Announced Financial Results for Fiscal Year 2023
XIAMEN, China , April 5, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ: LICN), a dedicated financial and taxation service provider in China, today announced its financial results for the fiscal year ended December 31, 2023. FY 2023 Financial Highlights: Revenue increased approximately $5.95 million or 17.61% to approximately $39.76 million for the year ended December 31, 2023, as compared with approximately $33.81 million for the fiscal year ended December 31, 2022.

Lichen China Limited Launches AI-Powered Software for Financial & Taxation Solutions
XIAMEN, China , March 25, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ: LICN), a dedicated financial and taxation service provider in China, today announced the launch of AI-powered software - Lichen AI Robot, which was developed on GPT-based technology. Lichen AI Robot will serve as the Company's virtual financial and tax advisor in the future, providing tailored financial and tax solutions for individuals and enterprises.

Lichen China Limited Expands Presence in International Markets
XIAMEN, China, March 14, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ:LICN), a dedicated financial and taxation service provider in China, today announced its expansion into international markets. Lichen China established its subsidiary in Singapore ("Lichen Singapore") in December 2023 and has now officially started operations.

Lichen China Limited Announces Appointment of Robert Bodenstein to Board of Directors
XIAMEN, China , Feb. 27, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ:LICN), a dedicated financial and taxation service provider in China, announced the appointment of Mr. Robert Bodenstein to its board of directors, effective February 26, 2024.

Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for LICN.